Saturday 17 October 2026 Export BTAIQ’s income statement to Excel — free account

BioXcel Therapeutics, Inc.

BTAIQ Healthcare Drug Manufacturers Specialty & Generic

BioXcel Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $642,000.00, down 71.7% from fiscal 2024. In the quarter to June 2026, revenue grew 51.7%, EPS grew 80.0%, free cash flow grew 51.5% and total debt fell 3.90%, each against the same quarter a year earlier.

0.03 0.00 0.00%

Follow BTAIQ

Alert me

Market cap: $2.3M
P/E: 0.0×
Fwd P/E: −0.4×
Dividend yield: —
F-score: 2/9
Altman Z: −26.30
Beneish M: −0.61
Dividend safety: n/a

Overview Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	1	2	2	4
ROE Full definition →		78.16%	74.14%	76.98%	63.52%
ROA Full definition →		(145.62%)	(167.91%)	(207.56%)	(259.62%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(996.07%)	770.98%	359.26%	65.40%
Average Days of Receivables Full definition →		0.00	132.47	115.94	40.34
Free Cash Flow per Share Full definition →		(4.10)	(4.72)	(2.43)	(1.68)
Free Cash Flow Full definition →		(58.21)	(57.61)	(57.38)	(50.90)
Other line items
Cash ROIC Full definition →		(101.20%)	(134.34%)	(481.14%)	(1,823.21%)
Accounts Receivable Turnover Full definition →		0.00	1.23	6.21	6.97
Accounts Payable Turnover Full definition →		0.06	0.01	0.03	0.02
Inventory Turnover Full definition →		0.97	0.23	0.76	0.70
Average Days of Payables Full definition →		6,168.99	32,718.69	13,695.51	19,700.56
Days of Inventory on Hand Full definition →		173.97	1,606.89	421.48	506.59
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		3,916.36%	4,711.99%	4,213.53%	2,905.66%
Selling, General and Administrative Expense of Revenue Full definition →		2,763.83%	3,192.21%	3,233.24%	3,176.01%
Share Based Compensation of Revenue Full definition →		281.65%	431.00%	444.41%	245.82%
Interest Coverage Full definition →		(3.05)	(2.97)	(2.94)	(2.61)
Operating CF/Net income Full definition →		0.85	0.82	0.76	0.72
Depreciation/Fixed assets Full definition →		1.22	1.71	2.41	2.27
Capex/Depreciation Full definition →		0.00	0.00	0.00	0.00
Revenue per Share Full definition →		0.05	0.05	0.03	0.02
Operating CF per Share Full definition →		(4.10)	(4.72)	(2.43)	(1.68)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly